Universit Laval competitive analysis

Explore Universit Laval's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 29, 2026
Patent NumberPublication DateTitleTotal Oppositions
Jan 21, 2026Composition For Reducing Hepatic Triglycerides And/Or Improving Glucose Metabolism1
Sep 19, 2018Use Of Rank/Rankl Antagonists For Treating Neuromuscular Disorders, Genetic Myopathies And/Or Non Genetic Myopathies And/Or For Regulating Skeletal And Cardiac Muscle Disuse, Diseases And Aging2

Latest PTAB cases involving Universit Laval

Discover the latest PTAB cases involving Universit Laval, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Universit Laval with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 29, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
UNIVERSIT LAVAL - 3 - -
FRESENIUS KABI DEUTSCHLAND18421 - -
ISENBRUCK BSL HRSCHLER19 - - -
PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBB20 - - -